News

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...
Huawei Digital Power is driving the renewable transition in SEE with its FusionSolar C&I ESS, integrating smart cooling, ...
The immediate reaction to the Colossal Biosciences’ claims from a broad section of the scientific community was highly ...
Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...
Per Derek Guy, 3sixteen co-founder Andrew Chen told his Instagram followers yesterday how his company (and their prices) will ...
Recovery in electricity demand, incremental demand from emerging sectors like 5G, artificial intelligence and policy support ...
We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...
We recently published a list of Jim Cramer Got These 10 Stocks All Wrong. In this article, we are going to take a look at ...
Policy measure to bring relief to domestic players who have suffered from cash flow challenges and reduced returns on capital due to dumped imports, say experts ...
In the midst of tariff mayhem this week, finally some good news has landed, with Orthocell gaining a big FDA approval win in ...
TCW Global Real Estate Fund, I Share Class, (the “Fund”) generated a return of -11.75% (net of fees) during the quarter, underperforming the S&P Global REIT Index gain of -8.78%.
ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.